Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
PHASE2CompletedINTERVENTIONAL
Enrollment
90
Participants
Timeline
Start Date
July 31, 2004
Study Completion Date
January 31, 2005
Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
DRUG
Phosphatidylserine-Omega3
Trial Locations (1)
64239
Clinical Nutrition Unit, Sourasky Medical Center, Tel Aviv
All Listed Sponsors
lead
Tel-Aviv Sourasky Medical Center
OTHER_GOV
NCT00382616 - Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD | Biotech Hunter | Biotech Hunter